Your browser doesn't support javascript.
loading
Human interleukin-2 receptor ß mutations associated with defects in immunity and peripheral tolerance.
Zhang, Zinan; Gothe, Florian; Pennamen, Perrine; James, John R; McDonald, David; Mata, Carlos P; Modis, Yorgo; Alazami, Anas M; Acres, Meghan; Haller, Wolfram; Bowen, Claire; Döffinger, Rainer; Sinclair, Jan; Brothers, Shannon; Zhang, Yu; Matthews, Helen F; Naudion, Sophie; Pelluard, Fanny; Alajlan, Huda; Yamazaki, Yasuhiro; Notarangelo, Luigi D; Thaventhiran, James E; Engelhardt, Karin R; Al-Mousa, Hamoud; Hambleton, Sophie; Rooryck, Caroline; Smith, Kenneth G C; Lenardo, Michael J.
Afiliación
  • Zhang Z; Cambridge Institute of Therapeutic Immunology and Infectious Disease, and the Department of Medicine, University of Cambridge, Cambridge, UK.
  • Gothe F; Molecular Development of the Immune System Section, Laboratory of Immune System Biology and Clinical Genomics Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Pennamen P; Harvard Medical School, Boston, MA.
  • James JR; Institute of Cellular Medicine, Newcastle University, Newcastle, UK.
  • McDonald D; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
  • Mata CP; University of Bordeaux, Maladies Rares: Génétique et Métabolisme Institut National de la Santé et de la Recherche Médicale U1211, Centre Hospitalier Universitaire de Bordeaux, Service de Génétique Médicale, Bordeaux, France.
  • Modis Y; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
  • Alazami AM; Institute of Cellular Medicine, Newcastle University, Newcastle, UK.
  • Acres M; Cambridge Institute of Therapeutic Immunology and Infectious Disease, and the Department of Medicine, University of Cambridge, Cambridge, UK.
  • Haller W; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
  • Bowen C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, and the Department of Medicine, University of Cambridge, Cambridge, UK.
  • Döffinger R; Molecular Immunity Unit, Department of Medicine, Medical Research Council Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
  • Sinclair J; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Brothers S; Institute of Cellular Medicine, Newcastle University, Newcastle, UK.
  • Zhang Y; Birmingham Children's Hospital, Birmingham, UK.
  • Matthews HF; Birmingham Children's Hospital, Birmingham, UK.
  • Naudion S; Department of Clinical Biochemistry and Immunology, Cambridge University Hospital, Cambridge, UK.
  • Pelluard F; Starship Children's Hospital, Auckland, New Zealand.
  • Alajlan H; Starship Children's Hospital, Auckland, New Zealand.
  • Yamazaki Y; Molecular Development of the Immune System Section, Laboratory of Immune System Biology and Clinical Genomics Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Notarangelo LD; Molecular Development of the Immune System Section, Laboratory of Immune System Biology and Clinical Genomics Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Thaventhiran JE; University of Bordeaux, Maladies Rares: Génétique et Métabolisme Institut National de la Santé et de la Recherche Médicale U1211, Centre Hospitalier Universitaire de Bordeaux, Service de Génétique Médicale, Bordeaux, France.
  • Engelhardt KR; Department of Pathology, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.
  • Al-Mousa H; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Hambleton S; Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology and Clinical Genomics Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Rooryck C; Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology and Clinical Genomics Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, and the Department of Medicine, University of Cambridge, Cambridge, UK.
  • Lenardo MJ; Institute of Cellular Medicine, Newcastle University, Newcastle, UK.
J Exp Med ; 216(6): 1311-1327, 2019 06 03.
Article en En | MEDLINE | ID: mdl-31040185
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Subunidad beta del Receptor de Interleucina-2 / Tolerancia Inmunológica / Inmunidad / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Exp Med Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Subunidad beta del Receptor de Interleucina-2 / Tolerancia Inmunológica / Inmunidad / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Exp Med Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido